RxDoctor Payments Data

Catherine Callan, APRN

Adult Health · New Britain, CTNPI 1861771958

Payments from drug & device makers

$590in general payments, 2019–2025

Across 23 payments — averaging $25.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$138
  • E.r. Squibb & Sons, L.L.C.$129
  • Johnson & Johnson$72
  • Pfizer$57
  • Amgen$49
  • Boehringer Ingelheim$31
  • plus $114 from 6 others

What the payments were for

  • Food & beverage$590100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$590 in reported general payments places this provider in the 55th percentile of 418 adult health providers in Connecticut.

See all adult health providers in Connecticut

Medicare billing

Part B allowed, 2024
$2,666
Medicare patients
32
Services billed
70

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan33$49,223
JardianceEmpagliflozin26$37,432
EliquisApixaban32$21,455
XareltoRivaroxaban21$19,590
Metoprolol Succinate56$1,113
Ezetimibe49$959
Torsemide23$448
Atorvastatin Calcium93$352
Carvedilol52$221
Lisinopril49$193
Furosemide63$171
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide13$145
Rosuvastatin Calcium17$134
Metoprolol Tartrate20$133
Amlodipine Besylate42$120

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$31$37,43226 claims
PfizerEliquis$57$21,45532 claims
Johnson & JohnsonXarelto$72$19,59021 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 418 adult health providers in Connecticut.

Other adult health in New Britain

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →